GSK warns of declining vaccine sales in 2024 due to lower demand for respiratory syncytial virus vaccines
GSK on Wednesday said sales of its vaccines would fall this year after weaker-than-expected sales results for respiratory syncytial virus (RSV) and shingles vaccines in the third quarter, sending its shares down 4 per cent in early trading.
ПОПУЛЯРНЫЕ ПОСТЫ
Spain’s vice-president Ribera blames floods on climate change
Ноябрь 22, 2024
Storm lashes northwestern US, killing two people
Ноябрь 22, 2024
Iceland volcano erupts for tenth time in three years
Ноябрь 22, 2024
A banana wrapped in duct tape sells for $6.2 million at auction
Ноябрь 22, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ